Status:
COMPLETED
Inflammatory Effect Comparison Between Fentanyl and Remifentanil in Mastectomy Under General Anesthesia
Lead Sponsor:
Udayana University
Conditions:
Breast Disease
Anesthesia
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
Mastectomy triggers stress and inflammation responses due to tissue trauma. Surgical stress will increase levels of hormones (adrenocorticotropic hormone, cortisol, antidiuretic hormone, epinephrine, ...
Eligibility Criteria
Inclusion
- Patients scheduled for a mastectomy under general anesthesia
- Patients aged 30-65 years old
- ASA physical status: I-II
Exclusion
- Refusal to be included in the study
- History of opioid allergies
- Long-term use of steroids
- Patients on β blockers medication
- History of diabetes, autoimmune disease, or heart disease
Key Trial Info
Start Date :
July 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04435925
Start Date
July 27 2020
End Date
April 30 2021
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanglah General Hospital
Denpasar, Bali, Indonesia, 80114